SecBot SecBot
PRESS-RELEASE ·Filed Mar 18, 2026

RVPH

Reviva Pharmaceuticals
NEUTRAL
Impact 4/10
Horizondays Processed8mo ago WireGlobeNewswire
Press release · Offering
Actionable Insight • Neutral

Monitor SEC filings for the prospectus supplement to assess offering size, pricing, and dilution impact. Given RVPH's small market cap ($14M), even a modest offering could result in significant dilution if priced near current levels.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$0.8300
T+0 close · Mar 18, 2026 · via day close
Latest settled
−15.66%
T+60 · $0.7000
Vs SPY
−30.01%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 19 $0.8300entry
  2. T+1 · 8mo ago −3.61%α −1.87% · $0.8000
  3. T+5 · 8mo ago −6.02%α −3.81% · $0.7800
  4. T+20 · 7mo ago +2.41%α −5.21% · $0.8500
  5. T+60 · 5mo ago −15.66%α −30.01% · $0.7000
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Reviva Pharmaceuticals (RVPH) announced plans for a public offering of common stock and warrants, with proceeds intended to fund its Phase 3 RECOVER-2 trial for brilaroxazine in schizophrenia and general corporate purposes. The offering size, pricing, and terms have not been disclosed, and completion is subject to market conditions.

Key Facts

  • Reviva Pharmaceuticals is conducting a public offering of common stock (or equivalents) and warrants.
  • All securities are being offered by the company; no selling shareholders mentioned.
  • A.G.P./Alliance Global Partners is the sole placement agent.
  • Proceeds will fund the RECOVER-2 Phase 3 trial for brilaroxazine, R&D, and general corporate purposes.
  • Offering will be made under an effective shelf registration (Form S-3, filed Feb 2024), with a preliminary prospectus supplement to be filed.
  • No specific offering size, price, or number of shares disclosed; terms subject to market conditions.

Financial Impact

Dilutive to existing shareholders once priced and completed; magnitude unknown pending final terms.

dilutioncashequity

Risk Factors

  • Potential for substantial dilution if offering is large relative to current market cap or priced at a discount.
  • Equity offering in a weak market environment may depress stock price ahead of and after pricing.
  • No assurance the offering will be completed due to market or regulatory conditions.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3258600

Track record

12 reports on RVPH

Performance horizon

2 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +22.98% at T+20 after the Jul 10, 2026 report. 2 of 4 went positive at some point.

Filters
  1. Nov 12, 20264d ago 8-K Neutral 3/10 No price data
  2. Nov 12, 20264d ago Press Release Neutral 4/10 Entry $0.3400 Now $0.3504 +3.07% settles Feb 11
  3. Nov 9, 20267d ago DEF 14A Neutral 4/10 Entry $0.3521 Now $0.3504 −0.47% settles Feb 8
  4. Aug 12, 202613w ago Press Release Neutral 4/10 Entry $0.3521 to $0.3521 Now $0.3504 −0.47% · 0.00% +5.48% vs SPY
  5. Jul 10, 202618w ago 25-NSE Bearish 7/10 Entry $0.6200 to $0.5000 Now $0.3504 +43.48% ▲ +19.35% +22.24% vs SPY
  6. May 13, 202626w ago Press Release Bearish 7/10 Entry $0.3900 to $0.4303 Now $0.3504 +10.14% ▼ −10.33% −6.74% vs SPY
  7. May 13, 202626w ago 8-K Bearish 8/10 Entry $0.3521 to $0.4775 Now $0.3504 +0.47% ▼ −35.62% −31.19% vs SPY
  8. Apr 15, 202630w ago 8-K Neutral 5/10 Entry $0.8900 to $0.5731 Now $0.3504 −60.62% ▼ −35.61% −43.74% vs SPY
  9. Mar 30, 202633w ago Press Release Mixed 6/10 Entry $0.6600 to $0.6000 Now $0.3504 −46.90% ▼ −9.09% −25.58% vs SPY
  10. Mar 18, 202634w ago Press Release Bearish 6/10 Entry $0.8300 to $0.7000 Now $0.3504 +57.78% ▲ +15.66% +30.01% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens Wed (11h 7m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 18, 2026